OptimizeRx (OPRX) Stock Forecast & Price Target

$4.80 -0.06 (-1.23%)

As of 01/17/2025 04:00 PM Eastern

OptimizeRx - Analysts' Recommendations and Stock Price Forecast (2025)

MarketBeat calculates consensus analyst ratings for stocks using the most recent rating from each Wall Street analyst that has rated a stock within the last twelve months. Each analyst's rating is normalized to a standardized rating score of 1 (sell), 2 (hold), 3 (buy) or 4 (strong buy). Analyst consensus ratings scores are calculated using the mean average of the number of normalized sell, hold, buy and strong buy ratings from Wall Street analysts. Each stock's consensus analyst rating is derived from its calculated consensus ratings score (0 to .5 = Strong Sell, .5 to 1 = Sell, 1 to 1.5 = Reduce, 1.5 to 2.5 = Hold, 2.5 to 3.0 = Moderate Buy, 3.0 to 3.5 = Buy, >3.5 = Strong Buy). MarketBeat's consensus price targets are a mean average of the most recent available price targets set by each analyst that has set a price target for the stock in the last twelve months. MarketBeat's consensus ratings and consensus price targets may differ from those calculated by other firms due to differences in methodology and available data.

Consensus Rating

Moderate Buy

Based on 9 Analyst Ratings

Sell
0

Hold
3

Buy
6

Based on 9 Wall Street analysts who have issued ratings for OptimizeRx in the last 12 months, the stock has a consensus rating of "Moderate Buy." Out of the 9 analysts, 3 have given a hold rating, and 6 have given a buy rating for OPRX.

Consensus Price Target

$9.06
88.80% Upside

According to the 9 analysts' twelve-month price targets for OptimizeRx, the average price target is $9.06. The highest price target for OPRX is $16.00, while the lowest price target for OPRX is $5.00. The average price target represents a forecasted upside of 88.80% from the current price of $4.80.

Get the Latest News and Ratings for OPRX and Related Stocks

Enter your email address to receive the latest news and analysts' ratings for OptimizeRx and its competitors.

OPRX Analyst Ratings Over Time

Type	Current Forecast 1/20/24 to 1/19/25	1 Month Ago 12/21/23 to 12/20/24	3 Months Ago 10/22/23 to 10/21/24	1 Year Ago 1/20/23 to 1/20/24
Strong Buy	0 Strong Buy rating(s)	0 Strong Buy rating(s)	0 Strong Buy rating(s)	0 Strong Buy rating(s)
Buy	6 Buy rating(s)	6 Buy rating(s)	4 Buy rating(s)	8 Buy rating(s)
Hold	3 Hold rating(s)	2 Hold rating(s)	1 Hold rating(s)	1 Hold rating(s)
Sell	0 Sell rating(s)	0 Sell rating(s)	0 Sell rating(s)	0 Sell rating(s)
Consensus Price Target	$9.06	$9.71	$14.50	$16.00
Forecasted Upside	88.80% Upside	97.85% Upside	138.88% Upside	6.95% Upside
Consensus Rating	Moderate Buy	Moderate Buy	Moderate Buy	Moderate Buy

OPRX Analyst Recommendations By Month

The chart below shows how a company's ratings by analysts have changed over time. Each bar represents the previous year of ratings for that month. Within each bar, the sell ratings are shown in red, the hold ratings are shown in yellow, the buy ratings are shown in green, and the strong buy ratings are shown in dark green.

OPRX Price Targets by Month

The chart below shows how a company's share price and consensus price target have changed over time. The dark blue line represents the company's actual price. The lighter blue line represents the stock's consensus price target. The even lighter blue range in the background of the two lines represents the low price target and the high price target for each stock.

OptimizeRx Stock vs. The Competition

Type	OptimizeRx	Computer and Technology Companies	S&P 500
Consensus Rating Score	2.67	2.69	2.52
Consensus Rating	Moderate Buy	Moderate Buy	Moderate Buy
Predicted Upside	88.80% Upside	255.68% Upside	12.44% Upside
News Sentiment Rating	Neutral News See Recent OPRX News	Neutral News	Positive News

Recent Analyst Forecasts and Stock Ratings

Rating

Upside/Downside

Action

Time Frame

Start Date

End Date

Show

Export to Excel

Date	Brokerage	Analyst Name	Action	Rating	Price Target	Upside/Downside on Report Date
1/8/2025	Royal Bank of Canada 4 of 5 stars	S. Dodge Subscribe to MarketBeat All Access for the recommendation accuracy rating	Reiterated Rating	Outperform ➝ Sector Perform	$7.00 ➝ $6.00	+3.09%
12/24/2024	Lake Street Capital 2 of 5 stars		Reiterated Rating	Buy ➝ Buy	$11.00 ➝ $11.00	+122.67%
12/24/2024	B. Riley 4 of 5 stars		Lower Target	Buy ➝ Buy	$17.00 ➝ $13.00	+160.52%
12/20/2024	Stephens Subscribe to MarketBeat All Access for the recommendation accuracy rating	J. Garro Subscribe to MarketBeat All Access for the recommendation accuracy rating	Initiated Coverage	Equal Weight	$5.50	+15.79%
11/14/2024	William Blair Subscribe to MarketBeat All Access for the recommendation accuracy rating		Reiterated Rating	Outperform
11/14/2024	Roth Mkm Subscribe to MarketBeat All Access for the recommendation accuracy rating		Reiterated Rating	Buy ➝ Buy	$20.00 ➝ $16.00	+262.81%
11/14/2024	Stifel Nicolaus Subscribe to MarketBeat All Access for the recommendation accuracy rating		Lower Target	Buy ➝ Buy	$13.00 ➝ $8.00	+83.91%
11/14/2024	Barclays Subscribe to MarketBeat All Access for the recommendation accuracy rating		Lower Target	Equal Weight ➝ Equal Weight	$11.00 ➝ $5.00	-18.70%
11/14/2024	JMP Securities Subscribe to MarketBeat All Access for the recommendation accuracy rating		Lower Target	Market Outperform ➝ Market Outperform	$16.00 ➝ $8.00	+30.08%
3/9/2023	Roth Capital Subscribe to MarketBeat All Access for the recommendation accuracy rating	R. Baldry Subscribe to MarketBeat All Access for the recommendation accuracy rating	Reiterated Rating	Buy
Get the Latest News and Ratings for OPRX and Related Stocks Enter your email address below to receive the latest news and analysts' ratings for OptimizeRx and its competitors with MarketBeat's FREE daily newsletter.
1/27/2023	Leerink Partners Subscribe to MarketBeat All Access for the recommendation accuracy rating	S. Davis Subscribe to MarketBeat All Access for the recommendation accuracy rating	Reiterated Rating	Outperform

Analyst ratings data on MarketBeat is provided by Benzinga and other data providers. This page was last refreshed on Sunday at 09:27 AM ET.

OPRX Forecast - Frequently Asked Questions

: According to the research reports of 9 Wall Street equities research analysts, the average twelve-month stock price forecast for OptimizeRx is $9.06, with a high forecast of $16.00 and a low forecast of $5.00.
: 9 Wall Street analysts have issued "buy," "hold," and "sell" ratings for OptimizeRx in the last year. There are currently 3 hold ratings and 6 buy ratings for the stock. The consensus among Wall Street analysts is that investors should "moderate buy" OPRX shares.
: According to analysts, OptimizeRx's stock has a predicted upside of 88.80% based on their 12-month stock forecasts.
: OptimizeRx has been rated by research analysts at B. Riley, Barclays, JMP Securities, Lake Street Capital, Roth Mkm, Royal Bank of Canada, Stephens, Stifel Nicolaus, and William Blair in the past 90 days.
: Analysts like OptimizeRx less than other "computer and technology" companies. The consensus rating score for OptimizeRx is 2.67 while the average consensus rating score for "computer and technology" companies is 2.69. Learn more on how OPRX compares to other companies.

Stock Forecasts and Research Tools

Related Companies

Today's Ratings

Top Rated Stocks

More Ratings Tools

This page (NASDAQ:OPRX) was last updated on 1/19/2025 by MarketBeat.com Staff

From Our Partners

Get 30 Days of MarketBeat All Access for Free

Start Your 30-Day Trial

In-depth profiles and analysis for 20,000 public companies.
Real-time analyst ratings, insider transactions, earnings data, and more.
Our daily ratings and market update email newsletter.

Sign In
Create Account

Your Email Address:

Your Password:

Forgot your password?

Your Email Address:

Choose a Password:

By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

OptimizeRx (OPRX) Stock Forecast & Price Target